FOSUN HEALTH Logo

Heart Failure Treatment

catalogue

Heart Failure Treatment

Heart Failure Treatment

Treatment for heart failure is not a single decision but a structure with three levels. At the base are four classes of medicine that treat the condition itself, and they are the reason the plan holds over years. Above them sit diuretics, which decide how the patient feels this week by removing fluid. Above both sit procedures and devices, which are added for specific patients at specific moments — usually once the medicines have had time to do their work. This page explains each level, why the order is what it is, and why the plan is built over weeks rather than written on one afternoon.

The four pillars: the part of the plan that treats the condition

When the ejection fraction is reduced, guideline-directed medical therapy means four classes of drug rather than one, and each class works through a different mechanism. They are introduced as a combination, at modest doses, and then increased — which is the opposite of the older habit of pushing one drug to its maximum before adding the next. The reason is practical: the four act on different parts of the same problem, and a patient on moderate doses of all four is in a different position from a patient on a large dose of one.

Pillar (drug class) What the class does What the patient should know
ARNI, or an ACE inhibitor or ARB Relaxes the blood vessels and reduces the load the heart has to pump against, while damping the hormone systems that drive the disease process The ARNI is usually preferred where it is available and tolerated, and it is not combined with an ACE inhibitor; blood pressure and kidney function are checked after each change
Beta blocker Slows the heart and reduces its work, and changes the heart's own signalling over time It starts at a low dose and goes up slowly; it can feel worse before it feels better, and it must not be stopped abruptly
Mineralocorticoid receptor antagonist (MRA) Blocks the hormone that holds on to salt and water and drives scarring, and helps the body shed sodium It needs potassium and kidney function checked, because those are exactly what it can disturb
SGLT2 inhibitor Causes salt and water to be lost in the urine and acts on the heart and the kidney by other routes as well It is used in heart failure whether or not the patient has diabetes; the usual advice covers genital hygiene and sick-day rules

Two honest notes belong with this table. Some patients cannot take all four — because of low blood pressure, a slow heart rate, advanced kidney disease or a high potassium — and the plan then becomes a considered compromise rather than a checklist; what matters is that the reason is recorded and reviewed, not that the box is ticked. And the doses are titrated against the patient, not against the leaflet: the target is the largest dose the patient tolerates comfortably, which is a different number in different people.

Diuretics: for how you feel this week

Diuretics are the drugs that remove the fluid, and they are the reason a patient who arrives breathless can be made comfortable quickly. They act on the kidney, so the effect is measured in the simplest possible way: more urine, less weight, less breathlessness, less swelling. Nearly everyone with congestion takes one, and it is the drug most often adjusted on the basis of a number the patient brings from home.

It is worth being clear about the division of labour, because patients frequently mistake one part of the plan for the other. The diuretic removes the fluid that has accumulated; it does not change the process that made the fluid accumulate. That is the work of the four classes described above. A patient whose diuretic has been increased feels better within days and may reasonably conclude that the extra tablet is the treatment — when the treatment is the plan that the diuretic is compensating for.

The sentence worth remembering: the diuretic decides how you feel this week, and the four pillars are the part of the plan that treats the disease. Both are needed, they are adjusted for different reasons, and a good week is not a reason to stop the second group. This is also why the dose of the diuretic is set by weight and by symptoms rather than by a fixed schedule.

Devices: two different questions, two different devices

Device treatment in heart failure is often discussed as if it were one decision. It is two, and they are worth keeping apart because they are asked for different reasons and answered by different devices.

Cardiac resynchronisation therapy is an electrical solution to a mechanical problem. When the electrical signal takes too long to cross the ventricle, the two sides contract out of step: one wall pushes while the other is still filling, and the work done is wasted. A resynchronisation device paces both sides so that they contract together again. The question it answers is decided from the electrocardiogram as much as from the echocardiogram — the width of the QRS complex, the ejection fraction, the functional class, and whether the patient remains limited after the medicines have been optimised. In the right patient, the benefit is measured in how far they can walk and how they feel, which is why the discussion is about the pattern on the ECG rather than about the diagnosis in general.

An implantable defibrillator answers a different question: not how the heart contracts, but what happens if a dangerous rhythm occurs. It is considered in two settings — after a rhythm event that has already happened despite treatment, and as a preventive measure in selected patients with a persistently reduced ejection fraction. The honest way to describe it is that it treats a risk rather than a symptom; a patient who receives one should expect to feel no different day to day, and should understand exactly why the clinic is raising a device that does not change how they feel. Both device questions are usually revisited after a period on the full medicine plan, because the medicines can change the numbers the decision rests on.

Treating what is behind the failure

Some heart failure is driven by something that can be repaired, and in those patients a procedure is part of the treatment of the failure itself rather than a separate specialty. Three groups are worth naming, because recognising them changes the plan.

Restoring blood supply. Where the muscle is short of blood — whether because of narrowed arteries, or because a segment of muscle has been left under-supplied since an infarction — revascularisation can improve how that segment contracts. This is why the search for coronary disease is part of the assessment rather than an optional extra: it is one of the few findings that can redirect treatment away from dose adjustment and towards a procedure.

Repairing or replacing a valve. Aortic stenosis and mitral regurgitation both place a load on the ventricle that can end in failure, and a leaky mitral valve can be a consequence of a dilated ventricle as well as a cause of it. Deciding which of those is true in a given patient takes imaging and often a direct measurement in the catheter laboratory, because a valve problem that is merely a consequence may not benefit from being fixed, while the same problem as a cause may change everything. The valve conditions themselves are described in their own guide.

Controlling the rhythm. A sustained fast rhythm can weaken a pump that was previously normal, and atrial fibrillation both aggravates heart failure and is aggravated by it. Restoring and maintaining a stable rhythm — by medication, by cardioversion or by ablation — is therefore a treatment of the failure in some patients, and it is considered early rather than as a last resort. Which of these three applies is a question about the cause, and the causes page sets out how each route is identified.

How the plan is built, and why it takes weeks

A heart failure plan is not a prescription written on one afternoon and then followed for a year. It is a sequence of small changes, each one made and then assessed, because every class of medicine that helps the heart can also lower the blood pressure, slow the pulse, or disturb the kidney and the potassium. The pace of the sequence is set by the patient's tolerance rather than by the calendar.

Relieve the congestion first

Nothing else can be judged while the patient is waterlogged. Fluid is removed until breathing and weight are back to a stable point, and only then does the rest of the plan become measurable.

Introduce the pillars one at a time

The classes that treat the condition are started at modest doses, with a check of blood pressure, pulse and bloods between them, so that a side effect can be attributed to a drug rather than to the disease.

Increase at intervals, against the numbers

Each dose increase is followed by a review of symptoms, blood pressure, kidney function and potassium. A patient who feels well on a moderate dose is not failing the plan; the target is the largest dose that suits them.

Then revisit the device and the procedure

Resynchronisation, a defibrillator, or a procedure on the arteries or a valve is considered once the medicines have had their effect, because the medicines can change the ejection fraction and the symptoms that the decision rests on.

The weeks this takes are the reason a single consultation rarely produces a finished plan, and the reason follow-up matters as much as the prescription. It is also the reason a patient should ask what the target dose is and what the next step will be: a plan with a stated next step is one that can be followed from another country, which is exactly what the routine on the living-well page is arranged to support.

Two modes of care: the acute admission and the long plan

Heart failure is treated in two quite different modes, and patients meet both. Recognising which mode they are in at any moment is the first thing every plan should make clear, because the goal, the setting and the time-scale are not the same.

The acute admission

The goal is to get the patient out of danger and back to their baseline as fast as possible: fluid is removed, breathing is supported if needed, the trigger — an infection, a rhythm change, an uncontrolled blood pressure, a stopped medicine — is identified and treated, and everything is monitored while it happens. The medicine plan is usually left broadly as it was, or simplified, until the patient is dry and stable enough to tolerate change.

The long plan

The goal is the opposite: not speed but durability. Doses are increased slowly, weight is recorded daily, rehabilitation builds capacity back, the cause is worked up and treated where possible, and the intervals between reviews are set. This is the mode in which the plan that keeps a patient out of hospital is actually built, and it runs for months and years rather than days.

The passage between the two is the part patients most often find confusing. Coming out of an admission, the diuretic dose is often higher than it will need to be later, and the plan is deliberately re-set at the follow-up visit rather than left as it was at discharge. That is why the follow-up appointment after an admission is not a formality: it is the appointment at which the acute mode hands over to the long one.

Frequently Asked Questions

Will I need all four of the medicines?

Most patients with a reduced ejection fraction are offered all four, because the four act in different ways and the combination is the point. That said, "all four at full dose" is a target rather than a rule. Low blood pressure, a slow pulse, advanced kidney disease or a high potassium can each limit what is possible, and the plan is then adjusted to the individual. What matters most is not the number of tablets but whether the reasons for leaving one out are written down and revisited at the next review.

Can I stop the diuretic once the swelling has gone?

The dose can usually be reduced, and often should be — but stopping it altogether on the strength of a normal-looking ankle is a different decision, and one better taken with the clinic. Diuretics are adjusted against weight and symptoms, and many patients need a small maintenance dose indefinitely, because the fluid that accumulates in heart failure is being retained by the body's own mechanisms rather than simply left over from one meal. A dose that is too low shows up as weight climbing over days; a dose that is too high shows up as dizziness, thirst and rising kidney values.

Do I need a defibrillator?

That depends on two things that are assessed rather than assumed: how reduced the ejection fraction remains after the medicines have been optimised, and whether a dangerous rhythm has already occurred. A defibrillator is offered in selected patients as protection against a rhythm event, not as a treatment for breathlessness or swelling — so a patient who receives one should not expect to feel any different, and a patient who does not should not read the decision as bad news. The question is usually revisited a few months into the full medicine plan, because the medicines can change the number it rests on.

What happens if the standard plan is not enough?

Then the questions change rather than stop. The first is whether everything reversible has been dealt with — the doses, the congestion, iron deficiency, the rhythm, the arteries, the valve. If a patient remains severely limited despite all of that, the options are mechanical support or transplantation in those who are suitable, and in those who are not, a plan focused on symptoms and comfort. That second plan is a treatment plan, not a withdrawal of treatment: it changes what is being aimed at, and it is discussed openly with the patient and the family rather than arrived at by default.

Ask for the plan, with the target doses written down

Send the current medication list with doses, the most recent weight record, the echocardiogram report and the latest bloods including kidney function and potassium. A cardiology team will return an opinion on whether the four classes are all represented, which doses could reasonably be increased, and what the next step of the plan should be.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*